Development of an LC–MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy
Authors:
- Oskar GonzalezOGOskar Gonzalez
- Rosa Maria AlonsoRARosa Maria Alonso
- Nerea FerreirósNFNerea Ferreirós
- Wolfgang WeinmannWWWolfgang Weinmann
- Ralf ZimmermannRZRalf Zimmermann
- Sebastian DresenSDSebastian Dresen
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 879 (3-4) , 243-252
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education (CTQ2006-11285, CTQ2009-11690, GIU07/02)
This publication has 26 references indexed in Scilit:
- Simultaneous determination of bisoprolol and hydrochlorothiazide in human plasma by HPLC coupled with tandem mass spectrometryJournal of Chromatography B, 2009
- Effects of nitazoxanide on pharmacokinetics and pharmacodynamics of a single dose of warfarinAmerican Journal of Health-System Pharmacy, 2009
- Metabolic Syndrome PandemicArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analysesJournal of Chromatography B, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimperide in plasmaJournal of Chromatography B, 2005
- Minimization of ion suppression in LC–MS/MS analysis through the application of strong cation exchange solid-phase extraction (SCX-SPE)Journal of Pharmaceutical and Biomedical Analysis, 2005
- Definition of Metabolic SyndromeCirculation, 2004
- Linear regression for calibration lines revisited: weighting schemes for bioanalytical methodsJournal of Chromatography B, 2002
- Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 2002